Skip to main content

Marc S Zumberg, MD

Cancer Specialist (Oncologist), Hematologist (Blood Disease Specialist)

Rated 4.8 out of 5 stars
Photo of Marc S Zumberg

Research at a glance

Top areas of exploration

  • Anticoagulants , 10 publications
  • Warfarin , 5 publications
  • Telangiectasia, Hereditary Hemorrhagic , 4 publications
  • Hematology , 4 publications

Research activity

62 publications

732 citations

Why is this important?

Active clinical trials

TAK-755-2001

This is a study of TAK-755 in adults with immune-mediated thrombotic thrombocytopenic purpura (iTTP). The main aim of this study is to determine the percentage of participants with a clinical (Part 1) or platelet (Part 2) response without plasma…

Investigator
Marc S Zumberg
Status
Accepting Candidates
Ages
Adults
Sexes
All

My publications

62 publications

2026

Doxycycline for epistaxis in hereditary hemorrhagic telangiectasia: genotype-stratified outcomes

Blood Vessels, Thrombosis & Hemostasis

Publisher's site

2026

BMPR2 Splice-Site Variant in a Patient With Pulmonary Arteriovenous Malformation and Delayed-Onset Pulmonary Arterial Hypertension: A Case Report and Mechanistic Phenocopy Hypothesis.

American journal of medical genetics. Part A

PubMed • Publisher's site

2026

A Cohort, Semi-Randomized, open label quality improvement patient blood management (PBM) comparison of point of care viscoelastic coagulation monitors in cardiac surgery.

Journal of clinical monitoring and computing

PubMed • Publisher's site

2026

A Diagnostic Journey through a Rare Hemostatic Disorder.

The journal of applied laboratory medicine

PubMed • Publisher's site